These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 12570842
1. A synthetic overview of new molecules with 5-HT1A binding affinities. Pessoa-Mahana H, Araya-Maturana R, Saitz CB, Pessoa-Mahana DC. Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842 [Abstract] [Full Text] [Related]
2. Arylpiperazine derivatives acting at 5-HT(1A) receptors. López-Rodríguez ML, Ayala D, Benhamú B, Morcillo MJ, Viso A. Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120 [Abstract] [Full Text] [Related]
3. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo. Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M. J Med Chem; 2012 Jul 26; 55(14):6375-80. PubMed ID: 22738316 [Abstract] [Full Text] [Related]
4. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors. Sabb AL, Vogel RL, Kelly MG, Palmer Y, Smith DL, Andree TH, Schechter LE. Bioorg Med Chem Lett; 2001 Apr 23; 11(8):1069-71. PubMed ID: 11327592 [Abstract] [Full Text] [Related]
5. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants. Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A. J Med Chem; 2001 Feb 01; 44(3):418-28. PubMed ID: 11462981 [Abstract] [Full Text] [Related]
6. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors. Chilmonczyk Z, Cybulski M, Iskra-Jopa J, Chojnacka-Wójcik E, Tatarczyńska E, Kłodzińska A, Leś A, Bronowska A, Sylte I. Farmaco; 2002 Apr 01; 57(4):285-301. PubMed ID: 11989808 [Abstract] [Full Text] [Related]
7. Active conformation of some arylpiperazine postsynaptic 5-HT(1A) receptor antagonists. Paluchowska MH, Bojarski AJ, Charakchieva-Minol S, Wesołowska A. Eur J Med Chem; 2002 Apr 01; 37(4):273-83. PubMed ID: 11960662 [Abstract] [Full Text] [Related]
8. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives. Berardi F, Colabufo NA, Giudice G, Perrone R, Tortorella V, Govoni S, Lucchi L. J Med Chem; 1996 Jan 05; 39(1):176-82. PubMed ID: 8568804 [Abstract] [Full Text] [Related]
9. The 5-HT1A receptor and its ligands: structure and function. Olivier B, Soudijn W, van Wijngaarden I. Prog Drug Res; 1999 Jan 05; 52():103-65. PubMed ID: 10396127 [Abstract] [Full Text] [Related]
10. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines. Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R. J Med Chem; 2001 Dec 06; 44(25):4431-42. PubMed ID: 11728188 [Abstract] [Full Text] [Related]
11. Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity. Heinrich T, Böttcher H, Schiemann K, Hölzemann G, Schwarz M, Bartoszyk GD, van Amsterdam C, Greiner HE, Seyfried CA. Bioorg Med Chem; 2004 Sep 15; 12(18):4843-52. PubMed ID: 15336263 [Abstract] [Full Text] [Related]
12. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes. Perez M, Jorand-Lebrun C, Pauwels PJ, Pallard I, Halazy S. Bioorg Med Chem Lett; 1998 Jun 02; 8(11):1407-12. PubMed ID: 9871775 [Abstract] [Full Text] [Related]
13. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents. Homan EJ, Copinga S, Elfström L, van der Veen T, Hallema JP, Mohell N, Unelius L, Johansson R, Wikström HV, Grol CJ. Bioorg Med Chem; 1998 Nov 02; 6(11):2111-26. PubMed ID: 9881101 [Abstract] [Full Text] [Related]
14. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. Dekeyne A, Rivet JM, Gobert A, Millan MJ. Neuropharmacology; 2001 Jun 02; 40(7):899-910. PubMed ID: 11378160 [Abstract] [Full Text] [Related]
15. Analogues of the potential antipsychotic agent 1192U90: amide modifications. Navas F, Tang FL, Schaller LT, Norman MH. Bioorg Med Chem; 1998 Jun 02; 6(6):811-23. PubMed ID: 9681147 [Abstract] [Full Text] [Related]
16. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists. Holmberg P, Sohn D, Leideborg R, Caldirola P, Zlatoidsky P, Hanson S, Mohell N, Rosqvist S, Nordvall G, Johansson AM, Johansson R. J Med Chem; 2004 Jul 29; 47(16):3927-30. PubMed ID: 15267230 [Abstract] [Full Text] [Related]
17. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V. J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097 [Abstract] [Full Text] [Related]
18. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635. Newman-Tancredi A, Verrièle L, Millan MJ. Br J Pharmacol; 2001 Jan 16; 132(2):518-24. PubMed ID: 11159702 [Abstract] [Full Text] [Related]
19. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands. Paluchowska MH, Dereń-Wesołek A, Mokrosz JL, Charakchieva-Minol S, Chojnacka-Wójcik E. Arch Pharm (Weinheim); 1996 Oct 16; 329(10):451-6. PubMed ID: 8933747 [Abstract] [Full Text] [Related]
20. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. Tottori K, Miwa T, Uwahodo Y, Yamada S, Nakai M, Oshiro Y, Kikuchi T, Altar CA. Neuropharmacology; 2001 Dec 16; 41(8):976-88. PubMed ID: 11747902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]